Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$19.8 million.

  • AC Immune's Consolidated Net Income fell 41210.51% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year decrease of 8960.07%. This contributed to the annual value of -$58.1 million for FY2024, which is 491.25% up from last year.
  • Latest data reveals that AC Immune reported Consolidated Net Income of -$19.8 million as of Q3 2025, which was down 41210.51% from -$25.6 million recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Consolidated Net Income peaked at $6.4 million during Q3 2024, and registered a low of -$25.6 million during Q2 2025.
  • For the 5-year period, AC Immune's Consolidated Net Income averaged around -$17.8 million, with its median value being -$19.5 million (2022).
  • As far as peak fluctuations go, AC Immune's Consolidated Net Income surged by 13706.28% in 2024, and later tumbled by 41210.51% in 2025.
  • Quarter analysis of 5 years shows AC Immune's Consolidated Net Income stood at -$23.1 million in 2021, then increased by 15.66% to -$19.5 million in 2022, then skyrocketed by 72.53% to -$5.3 million in 2023, then crashed by 237.25% to -$18.0 million in 2024, then fell by 9.95% to -$19.8 million in 2025.
  • Its Consolidated Net Income was -$19.8 million in Q3 2025, compared to -$25.6 million in Q2 2025 and -$21.2 million in Q1 2025.